Date Range
Date Range
Date Range
Dex Media, Inc.
Website Support
2200 West Airfield Drive PO Box 619810
DFW Airport, TX, 75261-4008
US
Developing novel topical medicines for gastrointestinal and ocular inflammatory diseases. TopiVert Pharma Ltd , a clinical-stage biotech focused on the local treatment of serious inflammatory diseases, today announced the start of a Phase I study with its lead compound, TOP1288, in ulcerative colitis. TopiVert is developing novel small molecule medicines as topical treatments for inflammatory diseases of the gut and eye. Download the document for more info.
Another microblog created, edited and archived by ALTACITIES. 9654;Content archived on Blogger. 9654;Following the SOCIAL in the.